Drawing for IN-BODY HOSPITALS

USPTO serial 79259172

IN-BODY HOSPITALS

Reviewed by CopyMark Law Group

Reg. 5929512Status 708Registered
Filing date
Status date
Registration date
Dec 10, 2019
Examiner
MCCLELLAN, MATTHEW D.
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with IN-BODY HOSPITALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations, namely, a drug delivery system comprising polymer micelle nanocarriers for targeted drug and gene delivery; pharmaceutical preparations, namely, an anticancer drug coated with polymer micelle; contrast media for use with MRI equipment; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets or powders that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral drug tablets, transdermal creams, compresses and patches for delivery of pharmaceuticals and injectable pharmaceuticals, all for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for cancer, brain tumor, Alzheimer, dementia, Parkinson's disease, hepatitis C, osteoarthritis, influenza, arteriosclerosis, spinal muscular atrophy, cerebral infarct, cerebral aneurysm, headache, epilepsy, ALS, myocardial infarction, angina, rheumatism, connective tissue disease, gout, measles, rubella, mumps, chickenpox, herpes zoster, tuberculosis, herpes, norovirus infection, hay fever and asthma; reagent paper for medical purposes ]SECTION 71 - CANCELLED
010[ Medical and diagnostic instruments made from organic compounds which circulate in the blood, accumulate at disease sites, such as cancer, and treat them; medical instruments made from organic or inorganic compounds which capture chemical and physical information from a disease site and bring it to an analyzer; MRI apparatus for medical purposes; MRI apparatus for medical purposes made from organic compounds; drug delivery systems; medical diagnostic apparatus for testing cancer cells; medical robots patrolling the microenvironment, detecting diseases and treating them in the body ]SECTION 71 - CANCELLED
044Medical services; provision of medical information; provision of medical information relating to pharmaceuticals; [ providing information relating to the rental of medical machines and apparatus; ] medical, medicinal and pharmaceutical consultancy [ ; medical equipment rental ]ACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 24, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 24, 2026C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 24, 2026EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 30, 2026PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Jan 26, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 25, 2025ES75TEAS SECTION 71 & 15 RECEIVED
Dec 10, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 24, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB
Mar 24, 2020XXCRGENERIC MADRID TRANSACTION CREATED
Mar 10, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2019GPNXNOTIFICATION PROCESSED BY IB
Sep 24, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 4, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 12, 2019RFNTREFUSAL PROCESSED BY IB
Jun 24, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2019RFRRREFUSAL PROCESSED BY MPU
Jun 4, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019MAFRAPPLICATION FILING RECEIPT MAILED
May 28, 2019DOCKASSIGNED TO EXAMINER
May 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
May 23, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance